Compare OBK & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBK | ATRC |
|---|---|---|
| Founded | 1912 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2018 | 2005 |
| Metric | OBK | ATRC |
|---|---|---|
| Price | $50.44 | $33.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | $46.67 | ★ $51.17 |
| AVG Volume (30 Days) | 136.3K | ★ 1.0M |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | ★ 0.89 | N/A |
| Revenue | N/A | ★ $201,630,000.00 |
| Revenue This Year | $26.43 | $15.27 |
| Revenue Next Year | $5.79 | $12.21 |
| P/E Ratio | $57.65 | ★ N/A |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $32.13 | $25.36 |
| 52 Week High | $52.90 | $43.18 |
| Indicator | OBK | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 51.43 | 70.66 |
| Support Level | $48.10 | $30.77 |
| Resistance Level | $50.35 | $34.38 |
| Average True Range (ATR) | 1.16 | 1.52 |
| MACD | -0.13 | 0.58 |
| Stochastic Oscillator | 40.21 | 96.42 |
Origin Bancorp Inc is a financial holding company that provides personalized, relationship banking to businesses, municipalities, and personal clients in the communities it serves. The company offers a broad range of financial services and operates more than 56 locations in Dallas/Fort Worth, East Texas, Houston, North Louisiana, Mississippi, South Alabama, and the Florida Panhandle. It also provides insurance agency products and services through its wholly owned insurance agency subsidiary. The company operates in one business segment, community banking, and is mainly engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.